132
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults

, , , , &
Pages 347-355 | Published online: 04 Oct 2012

References

  • Public Health Agency of Canada Obesity in Canada: A Joint Report from the Public Health Agency of Canada and the Canadian Institute for Health Information 2011 Available from: http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/index-eng.php Accessed August 13, 2012
  • Guh DP Zhang W Bansback N Amarsi Z Birmingham CL Anis AH The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis BMC Public Health 2009 9 88 19320986
  • Fontaine KR Barofsky I Obesity and health-related quality of life Obes Rev 2001 2 3 173 182 12120102
  • Badawi A Klip A Haddad P Cole DE Garcia-Bailo B El-Sohemy A Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention Diabetes Metab Syndr Obes 2010 3 173 186 21437087
  • Van Gaal LF Mertens IL De Block CE Mechanisms linking obesity with cardiovascular disease Nature 2006 444 7121 875 880 17167476
  • Bray GA Clearfield MB Fintel DJ Nelinson DS Overweight and obesity: the pathogenesis of cardiometabolic risk Clin Cornerstone 2009 9 4 30 40 19789062
  • Hotamisligil GS Inflammation and metabolic disorders Nature 2006 444 7121 860 867 17167474
  • Danesh J Collins R Appleby P Peto R Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 1998 279 18 1477 1482 9600484
  • Ridker PM Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity Nutr Rev 2007 65 12 Pt 2 S253 S259 18240558
  • García-Bailo B El-Sohemy A Haddad PS Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress Biologics 2011 5 7 19 21383912
  • Brenner DR Arora P García-Bailo B Plasma vitamin D levels and risk of metabolic syndrome in Canadians Clin Invest Med 2011 34 6 E377 22129928
  • Brenner DR Arora P García-Bailo B The relationship between metabolic syndrome and markers of cardiometabolic disease among Canadian adults J Diabetes Metab 2011 S2 3
  • Tremblay M Wolfson M Gorber SC Canadian Health Measures Survey: rationale, background and overview Health Rep 2007 18 Suppl S7 S20
  • Bryan S St-Denis M Wojtas D Canadian Health Measures Survey: clinic operations and logistics Health Rep 2007 18 Suppl S53 S70
  • Day B Langlois R Tremblay M Knoppers BM Canadian Health Measures Survey: ethical, legal and social issues Health Rep 2007 18 Suppl S37 S51
  • Giroux S Canadian Health Measures Survey: sampling strategy overview Health Rep 2007 18 Suppl S31 S36
  • Health Canada Canadian Guidelines for Body Weight Classification in Adults 2003 Available from: http://www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/index-eng.php Accessed August 13, 2012
  • Shields M Tremblay MS Laviolette M Craig CL Janssen I Gorber SC Fitness of Canadian adults: results from the 2007–2009 Canadian Health Measures Survey Health Rep 2010 21 1 21 35 20426224
  • Miller WM Nori-Janosz KE Lillystone M Yanez J McCullough PA Obesity and lipids Curr Cardiol Rep 2005 7 6 465 470 16256017
  • Bamba V Rader DJ Obesity and atherogenic dyslipidemia Gastroenterology 2007 132 6 2181 2190 17498511
  • Carr MC Brunzell JD Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk J Clin Endocrinol Metab 2004 89 6 2601 2607 15181030
  • Zhong L Li Q Jiang Y The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population Inflammation 2010 33 353 358 20213498
  • Walldius G Jungner I Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke Curr Opin Cardiol 2007 22 4 359 367 17556890
  • Barter PJ Ballantyne CM Carmena R Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: a report of the thirty-person/ten-country panel J Intern Med 2006 259 3 247 258 16476102
  • Florvall G Basu S Larsson A Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men J Gerontol Ser A Biol Sci Med Sci 2006 61 12 1262 1266 17234819
  • Wu JT Circulating homocysteine is an inflammation marker and a risk factor of life-threatening inflammatory diseases J Biomed Lab Sci 2007 19 4 107 111
  • Martí-Carvajal AJ Solà I Lathyris D Salanti G Homocysteine lowering interventions for preventing cardiovascular events Cochrane Database Syst Rev 10 7 2009 4 CD006612 19821378
  • Abraham JM Cho L The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med 2010 77 12 911 918 21147945
  • Nguyen XM Lane J Smith BR Nguyen NT Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation J Gastrointest Surg 2009 13 7 1205 1212 19415399
  • Papandreou D Mavromichalis I Makedou A Rousso I Arvanitidou M Total serum homocysteine, folate and vitamin B12 in a Greek school age population Clin Nutr 2006 25 5 797 802 16690175
  • Nakazato M Maeda T Takamura N Relation of body mass index to blood folate and total homocysteine concentrations in Japanese adults Eur J Nutr 2011 50 7 581 585 21221977
  • Matsuzawa Y Funahashi T Nakamura T The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism J Atheroscler Thromb 2011 18 8 629 639 21737960
  • Ghanim H Aljada A Hofmeyer D Syed T Mohanty P Dandona P Circulating mononuclear cells in the obese are in a proinflammatory state Circulation 2004 110 12 1564 1571 15364812
  • Pfützner A Schöndorf T Tschöpe D PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia Diabetes Technol Ther 2011 13 6 637 643 21457065
  • American Diabetes Association Executive summary: Standards of medical care in diabetes – 2010 Diabetes Care 2010 33 Suppl 1 S4 S10 20042774
  • Zajacova A Dowd JB Burgard SA Overweight adults may have the lowest mortality – do they have the best health? Am J Epidemiol 2011 173 4 430 437 21228416
  • Boeing H Weisgerber UM Jeckel A Rose H-J Kroke A Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: cross-sectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study Am J Clin Nutr 2000 71 5 1115 1122 10799373
  • Koga M Matsumoto S Saito H Kasayama S Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients Endocr J 2006 53 3 387 391 16717395
  • Mai XM Chen Y Camargo CAJr Langhammer A Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: The HUNT study Am J Epidemiol 2012 175 10 1029 1036 22312120
  • Brock K Huang WY Fraser DR Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women J Steroid Biochem Mol Biol 2010 121 1–2 462 466 20399270
  • Young KA Engelman CD Langefeld CD Association of plasma vitamin D levels with adiposity in Hispanic and African Americans J Clin Endocrinol Metab 2009 94 9 3306 3313 19549738
  • Hyppönen E Power C Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors Am J Clin Nutr 2007 85 3 860 868 17344510
  • Snijder MB van Dam RM Visser M Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women J Clin Endocrinol Metab 2005 90 7 4119 4123 15855256
  • Wortsman J Matsuoka LY Chen TC Lu Z Holick MF Decreased bioavailability of vitamin D in obesity Am J Clin Nutr 2000 72 3 690 693 10966885
  • McCarty MF Thomas CA PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight Med Hypotheses 2003 61 5–6 535 542 14592784
  • Veldman CM Cantorna MT DeLuca HF Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system Arch Biochem Biophys 2000 374 2 334 338 10666315